Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
RecruitingOBSERVATIONAL
Enrollment
103
Participants
Timeline
Start Date
August 19, 2021
Primary Completion Date
October 31, 2024
Study Completion Date
October 31, 2026
Conditions
Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer
Trial Locations (1)
Unknown
RECRUITING
Chih-Yuan Wang, M.D, Taipei
All Listed Sponsors
lead
National Taiwan University Hospital
OTHER
NCT04948437 - Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer | Biotech Hunter | Biotech Hunter